HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 111 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,718,550 | -68.5% | 45,000 | -53.1% | 0.02% | -70.2% |
| Q4 2022 | $5,462,400 | +43.9% | 96,000 | 0.0% | 0.06% | +32.6% |
| Q3 2022 | $3,796,000 | -10.1% | 96,000 | 0.0% | 0.04% | 0.0% |
| Q2 2022 | $4,224,000 | +231.0% | 96,000 | +200.0% | 0.04% | +290.9% |
| Q1 2022 | $1,276,000 | +10533.3% | 32,000 | +2566.7% | 0.01% | – |
| Q2 2014 | $12,000 | -98.6% | 1,200 | -98.2% | 0.00% | -100.0% |
| Q1 2014 | $839,000 | -50.3% | 66,075 | -41.4% | 0.00% | -60.0% |
| Q4 2013 | $1,689,000 | +3.6% | 112,697 | -23.7% | 0.01% | 0.0% |
| Q3 2013 | $1,631,000 | +145.6% | 147,697 | +76.6% | 0.01% | +150.0% |
| Q2 2013 | $664,000 | – | 83,622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |